treatment with a combination of daunorubicin ( 45 mg/m2 iv , days 1-3 ) and cytarabine ( 100 mg/m2 continuous iv infusion , days 4-10 ) failed to induce complete remission in 31 of 87 children ( 36 % ) with acute nonlymphocytic leukemia ( anll ) .
C0011015
daunorubicin
C0023467
acute nonlymphocytic leukemia